Abstract

This application is submitted in response to NOT-TR-20-014 as a supplement to Parent Award UL1TR002489, the North Carolina Translational and Clinical Sciences Institute (NC TraCS). This CTSA Administrative Supplement will add a dedicated quality assurance/quality control position to the NC TraCS Regulatory Knowledge and Support Program to perform quality reviews of CTSA-related submissions to NCATS, submissions to the eRA Human Subjects System, and management of the overall prior approval process. The following specific aims will be addressed by this supplement:
Aim 1 ? Create a dedicated position to oversee and manage internal processes for prior approval requests to NCATS.
Aim 2 ? Implement a comprehensive evaluation strategy to guide decision-making and ensure continuous improvement in processes.

Public Health Relevance

/Relevance The regulatory processes involved in translating biomedical discoveries into clinical applications are complex and evolve rapidly, often creating barriers that hinder the translation of discoveries into products to improve human health. The goal of the CTSA program is to tackle system-wide scientific and operational changes that solve the outstanding problems limiting the efficiency, effectiveness and reach of translational science. This application supports the CTSA goal by improving the accuracy, efficiency, and effectiveness of the regulatory process.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
3UL1TR002489-03S3
Application #
10158836
Study Section
Program Officer
Chang, Soju
Project Start
2018-03-30
Project End
2023-02-28
Budget Start
2020-07-01
Budget End
2021-02-28
Support Year
3
Fiscal Year
2020
Total Cost
Indirect Cost

  Institution

Name
University of North Carolina Chapel Hill
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599

  Publications

Peery, Anne F; Shaheen, Nicholas J; Cools, Katherine S et al. (2018) Morbidity and mortality after surgery for nonmalignant colorectal polyps. Gastrointest Endosc 87:243-250.e2
Buse, John B; D'Alessio, David A; Riddle, Matthew C (2018) Can We RISE to the Challenge of Youth-Onset Type 2 Diabetes? Diabetes Care 41:1560-1562
Kinlaw, Alan C; Jonsson Funk, Michele; Conover, Mitchell M et al. (2018) Impact of New Medications and $4 Generic Programs on Overactive Bladder Treatment Among Older Adults in the United States, 2000-2015. Med Care 56:162-170
Buglak, Nicholas E; Batrakova, Elena V; Mota, Roberto et al. (2018) Insights on Localized and Systemic Delivery of Redox-Based Therapeutics. Oxid Med Cell Longev 2018:2468457
Shah, Parth D; Calo, William A; Marciniak, Macary W et al. (2018) Service quality and parents' willingness to get adolescents HPV vaccine from pharmacists. Prev Med 109:106-112
Khairat, Saif; Ottmar, Paige; Sleath, Betsy et al. (2018) Facilitating the Informed Consent Process Using Teleconsent: Protocol for a Feasibility and Efficacy Study. JMIR Res Protoc 7:e11239
Hailey, Claire E; Yopp, Justin M; Deal, Allison M et al. (2018) Communication with children about a parent's advanced cancer and measures of parental anxiety and depression: a cross-sectional mixed-methods study. Support Care Cancer 26:287-295
Lachiewicz, Anne M; van Duin, David (2018) Reply to Elamin et al. Clin Infect Dis 67:982-983
Halladay, Jacqueline R; Lenhart, Kaitlin C; Robasky, Kimberly et al. (2018) Applicability of Precision Medicine Approaches to Managing Hypertension in Rural Populations. J Pers Med 8:
Dhatariya, Ketan; Bain, Stephen C; Buse, John B et al. (2018) The Impact of Liraglutide on Diabetes-Related Foot Ulceration and Associated Complications in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events: Results From the LEADER Trial. Diabetes Care 41:2229-2235

Showing the most recent 10 out of 76 publications